AZATHIOPRINE-50 TABLET

国家: 加拿大

语言: 英文

来源: Health Canada

现在购买

下载 产品特点 (SPC)
11-02-2020

有效成分:

AZATHIOPRINE

可用日期:

PRO DOC LIMITEE

ATC代码:

L04AX01

INN(国际名称):

AZATHIOPRINE

剂量:

50MG

药物剂型:

TABLET

组成:

AZATHIOPRINE 50MG

给药途径:

ORAL

每包单位数:

100

处方类型:

Prescription

治疗领域:

IMMUNOSUPPRESSIVE AGENTS

產品總結:

Active ingredient group (AIG) number: 0101830001; AHFS:

授权状态:

CANCELLED POST MARKET

授权日期:

2023-07-10

产品特点

                                PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
PR
AZATHIOPRINE-50
AZATHIOPRINE TABLETS USP
50 MG
IMMUNOSUPPRESSIVE AGENT
PRO DOC LTÉE
Date of Revision:
2925, Boul. Industriel,
February 11, 2020
Laval, Quebec
H7L 3W9
Submission Control No.: 235658
_AZATHIOPRINE-50 Product Monograph _
_ _
Page 2 of 29
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
............................................................................
3
SUMMARY PRODUCT INFORMATION
..................................................................................................
3
INDICATIONS AND CLINICAL USE
........................................................................................................
3
CONTRAINDICATIONS
.............................................................................................................................
3
WARNINGS AND PRECAUTIONS
............................................................................................................
4
ADVERSE REACTIONS
..............................................................................................................................
9
DRUG INTERACTIONS
............................................................................................................................
11
DOSAGE AND ADMINISTRATION
........................................................................................................
12
OVERDOSAGE
..........................................................................................................................................
13
ACTION AND CLINICAL PHARMACOLOGY
......................................................................................
13
STORAGE AND STABILITY
....................................................................................................................
15
SPECIAL HANDLING INSTRUCTIONS
.................................................................................................
15
DOSAGE FORMS, COMPOSITION AND PACKAGING
..................................
                                
                                阅读完整的文件
                                
                            

其他语言的文件

产品特点 产品特点 法文 11-02-2020

搜索与此产品相关的警报